| CH655656B (en)* | 1982-10-07 | 1986-05-15 | | |
| CA1225594A (en)* | 1983-05-20 | 1987-08-18 | Jourge Heller | Method for percutaneously administering physiologically active agents |
| DE3406497A1 (en)* | 1984-02-23 | 1985-09-05 | Mueller Bernhard Willi Werner | HIGHLY DISPERSAL PHARMACEUTICAL MULTI-COMPONENT SYSTEMS AND METHOD FOR THEIR PRODUCTION |
| WO1985003878A1 (en)* | 1984-03-01 | 1985-09-12 | Sandoz Ag | Pharmaceutical compositions |
| US5364628A (en)* | 1985-05-31 | 1994-11-15 | Sandoz Ltd. | Pharmaceutical compositions |
| US5639724A (en)* | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
| JPS61280426A (en)* | 1985-06-04 | 1986-12-11 | Ikeda Mohandou:Kk | Anti-inflammatory and analgesic application agent |
| US4767625A (en)* | 1985-09-02 | 1988-08-30 | Kao Corporation | Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same |
| US4690774A (en) | 1985-09-11 | 1987-09-01 | Chesebrough Pond's Inc. | Novel translucent water in oil emulsions |
| US4797272A (en) | 1985-11-15 | 1989-01-10 | Eli Lilly And Company | Water-in-oil microemulsions for cosmetic uses |
| DE3805744C2 (en)* | 1987-03-04 | 1999-09-23 | Novartis Ag | Phenylcarbamate for the inhibition of acetylcholinesterase |
| IL88076A (en)* | 1987-10-28 | 1993-01-14 | Nippon Shinyaku Co Ltd | Fat emulsions as drug carriers |
| US5342625A (en)* | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
| US6007840A (en)* | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
| GB2222770B (en)* | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
| US5241925A (en)* | 1988-12-27 | 1993-09-07 | Dermamed | Apparatus and techniques for administering veterinary medicaments |
| US5332577A (en)* | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
| US7081445B2 (en) | 1989-02-20 | 2006-07-25 | Novartis Ag | Cyclosporin galenic forms |
| DE3908047A1 (en)* | 1989-03-13 | 1990-09-20 | Desitin Arzneimittel Gmbh | HIGH DISPERSES PHARMACEUTICAL COMPOSITION |
| US5324521A (en)* | 1989-12-18 | 1994-06-28 | Dermamed | Systems for transdermal administration of medicaments |
| US5149719A (en)* | 1990-04-27 | 1992-09-22 | Minnesota Mining And Manufacturing Company | Composition for transdermal penetration of medicaments |
| FR2673537B1 (en)* | 1991-03-08 | 1993-06-11 | Oreal | USE OF HYDROPHILIC PENETRATION AGENTS IN DERMATOLOGICAL COMPOSITIONS FOR THE TREATMENT OF ONYCHOMYCOSES, AND CORRESPONDING COMPOSITIONS. |
| US5688761A (en)* | 1991-04-19 | 1997-11-18 | Lds Technologies, Inc. | Convertible microemulsion formulations |
| AU668509B2 (en)* | 1991-04-19 | 1996-05-09 | Affinity Biotech, Inc. | Convertible microemulsion formulations |
| HU223343B1 (en)* | 1991-05-20 | 2004-06-28 | Novartis Ag. | Compositions comprising allylamine derivatives, and process for their preparation |
| US6005001A (en)* | 1991-05-20 | 1999-12-21 | Novartis Ag (Formerly Sandoz Ag) | Pharmaceutical composition |
| GB9111611D0 (en)* | 1991-05-30 | 1991-07-24 | Sandoz Ltd | Liposomes |
| US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
| GB9126209D0 (en)* | 1991-12-10 | 1992-02-12 | Orion Yhtymae Oy | Drug formulations for parenteral use |
| WO1993011798A1 (en)* | 1991-12-16 | 1993-06-24 | Alza Corporation | Improved formulations with hydrophobic permeation enhancers |
| US5629019A (en)* | 1992-02-27 | 1997-05-13 | Alza Corporation | Formulations with hydrophobic permeation enhancers |
| WO1993023010A1 (en) | 1992-05-13 | 1993-11-25 | Sandoz Ltd. | Ophthalmic compositions containing a cyclosporin |
| DK0589843T3 (en) | 1992-09-25 | 2002-04-02 | Novartis Ag | Cyclosporin-containing pharmaceutical preparations |
| JPH08505367A (en)* | 1992-10-16 | 1996-06-11 | スミスクライン・ビーチャム・コーポレイション | Pharmaceutical emulsion composition |
| EP0684832A4 (en)* | 1993-02-17 | 1996-09-11 | Smithkline Beecham Corp | Microemulsions containing pharmaceutical compositions. |
| ATE218359T1 (en) | 1994-11-03 | 2002-06-15 | Novartis Erfind Verwalt Gmbh | NEW PREPARATION FORMS OF CYCLOSPORIN FOR ORAL APPLICATION WITH SIMPLE COMPOSITION AND HIGH BIOAVAILABILITY AND METHOD FOR THE PRODUCTION THEREOF |
| DE4442999A1 (en)* | 1994-12-02 | 1996-06-05 | Hexal Pharma Gmbh | Pharmaceutical composition containing an active loratidine metabolite |
| DE19549852B4 (en) | 1995-11-29 | 2009-06-04 | Novartis Ag | Cyclosporin containing preparations |
| US5958876A (en)* | 1996-06-19 | 1999-09-28 | Novartis Ag | Cyclosporin-containing pharmaceutical compositions |
| JP2000516256A (en) | 1997-01-30 | 2000-12-05 | ノバルティス アクチエンゲゼルシャフト | Oil-free pharmaceutical composition containing cyclosporin A |
| IN188719B (en)* | 1997-09-08 | 2002-11-02 | Panacea Biotec Ltd | |
| US6187747B1 (en) | 1997-09-08 | 2001-02-13 | Panacea Biotech Limited | Pharmaceutical composition comprising cyclosporin |
| US6346511B1 (en) | 1997-09-08 | 2002-02-12 | Panacea Biotec Limited | Pharmaceutical composition comprising cyclosporin |
| US6008191A (en)* | 1997-09-08 | 1999-12-28 | Panacea Biotec Limited | Pharmaceutical compositions containing cyclosporin |
| UY25225A1 (en) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | PLEUROMUTILINE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS |
| US6391282B1 (en)* | 1997-11-10 | 2002-05-21 | Flemington Pharmaceutical Corp. | Antihistamine sprays and ointments for relief of delayed contact dermatitis |
| DE19825856A1 (en)* | 1998-06-10 | 1999-12-16 | Labtec Gmbh | New topical formulation which includes active agent as liquid lipid nanoparticles in an oil-in-water emulsion |
| JP2002531515A (en) | 1998-12-11 | 2002-09-24 | ファーマソリューションズ・インコーポレイテッド | Self-emulsifying compositions for poorly water soluble drugs |
| US7374779B2 (en)* | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
| EP1644004A4 (en)* | 2003-06-20 | 2010-10-06 | Ronald Aung-Din | Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions |
| US20060078580A1 (en) | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| US7740875B2 (en) | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| US9308203B2 (en)* | 2008-10-01 | 2016-04-12 | Taiwan Biotech Co., Ltd. | Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis |
| US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
| WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
| US20160361322A1 (en) | 2015-06-15 | 2016-12-15 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| CA3078723A1 (en) | 2016-11-28 | 2018-05-31 | Nachiappan Chidambaram | Oral testosterone undecanoate therapy |
| CA3107214A1 (en) | 2018-07-20 | 2020-01-23 | Lipocine Inc. | Liver disease |